Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity

NANot yet recruitingINTERVENTIONAL

Enrollment

392

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Polycystic Ovary SyndromeObesityInfertility, Female

Interventions

DRUG

GLP-1 receptor agonist

3 months

DRUG

Metformin

3 months

BEHAVIORAL

healthy lifestyle education

3 months

Trial Locations (1)

Peking University Third Hospital, Beijing

All Listed Sponsors

lead

Peking University Third Hospital

OTHER

NCT06775093 - Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity | Biotech Hunter | Biotech Hunter